Connection

AIKATERINI ANAGNOSTOU to Administration, Oral

This is a "connection" page, showing publications AIKATERINI ANAGNOSTOU has written about Administration, Oral.
Connection Strength

2.599
  1. Development and acceptability of a decision-aid for food allergy oral immunotherapy in children. Allergy. 2025 01; 80(1):205-214.
    View in: PubMed
    Score: 0.181
  2. Addressing common questions on food oral immunotherapy: a practical guide for paediatricians. Arch Dis Child. 2024 08 16; 109(9):697-701.
    View in: PubMed
    Score: 0.180
  3. A Review of Shared Decision-Making, Published Protocols, and Post-desensitization Strategies in Oral Immunotherapy (OIT). Curr Allergy Asthma Rep. 2024 04; 24(4):173-197.
    View in: PubMed
    Score: 0.174
  4. Food Oral Immunotherapy: A Survey Among US Practicing Allergists Conducted as a AAAAI Leadership Institute Project and Work Group Report. J Allergy Clin Immunol Pract. 2023 08; 11(8):2330-2334.
    View in: PubMed
    Score: 0.165
  5. Food immunotherapy: current status and future needs. Expert Rev Clin Immunol. 2023 06; 19(6):561-563.
    View in: PubMed
    Score: 0.164
  6. Are There Hidden Dangers Associated With Milk and Egg Dietary Advancement Therapy? J Allergy Clin Immunol Pract. 2023 04; 11(4):1056-1062.
    View in: PubMed
    Score: 0.161
  7. Anaphylaxis during Peanut Oral Immunotherapy: Looking beyond dose escalation. Pediatr Allergy Immunol. 2022 12; 33(12):e13888.
    View in: PubMed
    Score: 0.160
  8. Management of Anaphylaxis During Peanut Oral Immunotherapy. Curr Allergy Asthma Rep. 2023 01; 23(1):21-27.
    View in: PubMed
    Score: 0.160
  9. Qualitative interviews to understand health care providers' experiences of prescribing licensed peanut oral immunotherapy. BMC Res Notes. 2022 Aug 08; 15(1):273.
    View in: PubMed
    Score: 0.156
  10. Weighing the benefits and risks of oral immunotherapy in clinical practice. Allergy Asthma Proc. 2021 03 01; 42(2):118-123.
    View in: PubMed
    Score: 0.142
  11. Food immunotherapy: Choosing wisely. Clin Exp Allergy. 2021 01; 51(1):9-13.
    View in: PubMed
    Score: 0.138
  12. Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy. Ann Allergy Asthma Immunol. 2020 08; 125(2):196-201.e1.
    View in: PubMed
    Score: 0.133
  13. Food immunotherapy for children with food allergies: state of the art and science. Curr Opin Pediatr. 2018 12; 30(6):798-805.
    View in: PubMed
    Score: 0.121
  14. Oral Immunotherapy for Peanut Allergy. Annu Rev Med. 2016; 67:375-85.
    View in: PubMed
    Score: 0.097
  15. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014 Apr 12; 383(9925):1297-1304.
    View in: PubMed
    Score: 0.087
  16. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy. 2011 Sep; 41(9):1273-81.
    View in: PubMed
    Score: 0.071
  17. Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent. J Allergy Clin Immunol. 2024 Jun; 153(6):1621-1633.
    View in: PubMed
    Score: 0.044
  18. Oral food challenges: Measuring what counts. J Allergy Clin Immunol. 2023 07; 152(1):50-52.
    View in: PubMed
    Score: 0.041
  19. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Ann Allergy Asthma Immunol. 2022 12; 129(6):758-768.e4.
    View in: PubMed
    Score: 0.039
  20. Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study). J Allergy Clin Immunol Pract. 2022 02; 10(2):566-576.e6.
    View in: PubMed
    Score: 0.037
  21. Using data from food challenges to inform management of consumers with food allergy: A?systematic review with individual participant data meta-analysis. J Allergy Clin Immunol. 2021 06; 147(6):2249-2262.e7.
    View in: PubMed
    Score: 0.035
  22. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study. J Allergy Clin Immunol Pract. 2021 05; 9(5):1879-1889.e13.
    View in: PubMed
    Score: 0.035
  23. Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? J Allergy Clin Immunol. 2020 04; 145(4):1153-1156.
    View in: PubMed
    Score: 0.032
  24. AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med. 2018 Nov 22; 379(21):1991-2001.
    View in: PubMed
    Score: 0.030
  25. Successful oral tolerance induction in severe peanut allergy. Allergy. 2009 Aug; 64(8):1218-20.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.